Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V K Langmuir

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|February 1, 1992
Radioimmunotherapy: clinical results and dosimetric considerationsV K Langmuir
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1996
The use of radioimmunotherapy in combination with bioreductive agentsV K Langmuir
Medical Physics|November 1, 1988
Dosimetry models for radioimmunotherapyV K Langmuir, R M Sutherland
Radiation Research|December 1, 1992
The combined use of 131I-labeled antibody and the hypoxic cytotoxin SR 4233 in vitro and in vivoV K Langmuir, H L Mendonca
Medical Physics|March 1, 1993
Experimental radioimmunotherapyD J Buchsbaum, V K Langmuir, B W Wessels
Cancer Research|September 1, 1992
Comparisons between two monoclonal antibodies that bind to the same antigen but have differing affinities: uptake kinetics and 125I-antibody therapy efficacy in multicell spheroidsV K Langmuir, H L Mendonca, D V Woo
Frontiers of Radiation Therapy and Oncology|January 1, 1990
Modulators of tumor responsiveness to radioimmunotherapyJ K McGann, V K Langmuir, R M Sutherland
Acta Cytologica|January 1, 1989
Fine needle aspiration cytology in the management of palpable benign and malignant breast disease. Correlation with clinical and mammographic findingsV K Langmuir, S F Cramer, M E Hood
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
The effect of antigen concentration, antibody valency and size, and tumor architecture on antibody binding in multicell spheroidsV K Langmuir, J K McGann, F Buchegger, et al.
Cancer Research|June 15, 1989
131I-anticarcinoembryonic antigen therapy of LS174T human colon adenocarcinoma spheroidsV K Langmuir, J K McGann, F Buchegger, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|February 1, 1992
Radioimmunotherapy: clinical results and dosimetric considerationsV K Langmuir
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1996
The use of radioimmunotherapy in combination with bioreductive agentsV K Langmuir
Medical Physics|November 1, 1988
Dosimetry models for radioimmunotherapyV K Langmuir, R M Sutherland
Radiation Research|December 1, 1992
The combined use of 131I-labeled antibody and the hypoxic cytotoxin SR 4233 in vitro and in vivoV K Langmuir, H L Mendonca
Medical Physics|March 1, 1993
Experimental radioimmunotherapyD J Buchsbaum, V K Langmuir, B W Wessels
Cancer Research|September 1, 1992
Comparisons between two monoclonal antibodies that bind to the same antigen but have differing affinities: uptake kinetics and 125I-antibody therapy efficacy in multicell spheroidsV K Langmuir, H L Mendonca, D V Woo
Frontiers of Radiation Therapy and Oncology|January 1, 1990
Modulators of tumor responsiveness to radioimmunotherapyJ K McGann, V K Langmuir, R M Sutherland
Acta Cytologica|January 1, 1989
Fine needle aspiration cytology in the management of palpable benign and malignant breast disease. Correlation with clinical and mammographic findingsV K Langmuir, S F Cramer, M E Hood
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
The effect of antigen concentration, antibody valency and size, and tumor architecture on antibody binding in multicell spheroidsV K Langmuir, J K McGann, F Buchegger, et al.
Cancer Research|June 15, 1989
131I-anticarcinoembryonic antigen therapy of LS174T human colon adenocarcinoma spheroidsV K Langmuir, J K McGann, F Buchegger, et al.
Pageof 2